查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497567

麻醉剂市场：按药物类型、给药途径、应用、剂型、最终用户划分 - 全球预测 2024-2030

Anesthetic Drugs Market by Drug Type (General Anesthesia Drugs, Local Anesthesia Drugs, Regional Anesthesia), Route of Administration (Inhalation, Injection), Application, Mode of Administration, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年麻醉剂市场规模为50.3亿美元，预计2024年将达53.5亿美元，2030年将达到78.3亿美元，复合年增长率为6.54%。

麻醉剂是用于诱导麻醉的医疗物质，麻醉会导致暂时失去知觉和意识，促进包括手术在内的医疗程序，而不会对病人造成疼痛或不适。由于慢性疾病、事故和人口老化的增加，全世界外科手术的数量不断增加，对麻醉剂的需求也增加。人们对无痛手术重要性的认识不断提高，加上医疗基础设施的加强，导致世界各地的医疗机构越来越多地采用麻醉剂。此外，需要有效麻醉和快速恢復的门诊病人和门诊手术的增加进一步推动了麻醉剂的使用。然而，实现正确的配方和剂量以及确保有效的药物传递的复杂性阻碍了麻醉剂的普及。此外，与不良药物交互作用、副作用、稳定性和溶解度相关的性能问题引起了对麻醉剂功效和安全性的担忧。能够实现更有针对性的麻醉、减少副作用和改善患者治疗效果的技术创新带来了巨大的机会。奈米技术也正在探索改善药物传输和功效、提供精确剂量并减少全身副作用。

主要市场统计
基准年[2023] 50.3亿美元
预测年份 [2024] 53.5亿美元
预测年份 [2030] 78.3亿美元
复合年增长率（%） 6.54%

区域洞察

北美，特别是美国和加拿大，由于先进的医疗保健架构、强​​劲的医疗支出以及持续的研发活动，代表了麻醉剂的成熟格局。美国对麻醉剂的需求是由于择期手术和急诊手术数量的增加以及疼痛管理的重要性日益增加而推动的。最近的趋势包括投资麻醉研究，以开发更安全、更有效、恢復更快、副作用更少的药物。这些国家的专利活动通常着重于改进药物配方和递送方法。欧盟国家的优势在于拥有统一的法律规范，使他们能够简化引入新麻醉剂的过程。人口快速老化也需要有效的疼痛管理解决方案。欧盟最近的研究重点是最大限度地减少麻醉气体对环境的影响，同时改善病患的治疗效果。亚太地区麻醉剂市场正在快速成长。推动这一增长的是医疗保健基础设施的扩张和医疗保健支出的增加。政府努力扩大获得医疗保健解决方案的机会，进一步推动了麻醉剂的采用。此外，该地区的另一个特点是诊所、外科中心以及私立和公立医院的扩张。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在麻醉剂市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对麻醉剂市场供应商的现状进行深入而详细的评估。对供应商贡献的彻底比较和分析可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对当前麻醉剂市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球手术数量增加
      • 术后疼痛缓解方案的需求显着增加
      • 人口老化加剧以及心血管和呼吸系统相关疾病的盛行率
    • 抑制因素
      • 与氯胺酮等药物相关的副作用
    • 机会
      • 药物传输技术的进展
      • 医疗成本增加及新药开发
    • 任务
      • 缺乏熟练的麻醉师
  • 市场区隔分析
    • 药物类型：广泛和侵入性手术对全身麻醉剂的迫切需求
    • 应用：在一般外科手术中使用麻醉剂促进有效的疼痛管理
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章麻醉剂市场药品种类

  • 全身麻醉剂
  • 局部麻醉剂
  • 局部麻醉

第七章麻醉剂市场：依给药途径

  • 吸入
  • 注射

第八章麻醉剂市场：依应用分类

  • 整容手术
  • 牙科手术
  • 一般外科
  • 整形外科

第九章麻醉剂市场管理方式

  • 吸入
  • 静脉

第 9 章 4. 主题：

第 10 章麻醉剂市场：依最终用户分类

  • 门诊手术中心
  • 诊所
  • 医院

第十一章美洲麻醉剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太麻醉剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲麻醉剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 百特国际透过创新註射剂扩大美国产品组合
    • Hikma Pharmaceuticals 推出Fentanyl注射液，扩大其在美国市场的产品范围
    • 术后疼痛管理的进展： FDA 长效局部麻醉剂开发新指南
  • 战略分析和建议

第15章竞争组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-434CCDA05121

[188 Pages Report] The Anesthetic Drugs Market size was estimated at USD 5.03 billion in 2023 and expected to reach USD 5.35 billion in 2024, at a CAGR 6.54% to reach USD 7.83 billion by 2030.

Anesthetic drugs are medical substances used to induce anesthesia, which is a temporary loss of sensation or awareness, facilitating medical procedures, including surgeries, without pain or discomfort for the patient. The global increase in the number of surgical interventions due to rising incidences of chronic diseases, accidents, and aging populations has created a need for anesthetic drugs. Enhanced healthcare infrastructure, along with growing awareness about the importance of painless procedures, has led to an increased adoption of anesthetic drugs in healthcare facilities across the world. Moreover, the rise in outpatient and ambulatory care surgeries, which require effective and fast-recovery anesthesia, further propels the utilization of anesthetic drugs. However, complexities in achieving the correct formulation or dosage and ensuring effective delivery of the medicine present a hurdle to the widespread adoption of anesthetic drugs. Morever, performance issues associated with adverse drug interactions, side effects, stability, and solubility can raise concerns about the efficacy and safety of anesthetic drugs. Innovations that allow for more targeted anesthesia, reducing side effects, and improving patient outcomes present a significant opportunity. Utilizing nano-technology to improve drug delivery and effectiveness, offering precise dosing, and reducing systemic side effects are also being explored.

KEY MARKET STATISTICS
Base Year [2023] USD 5.03 billion
Estimated Year [2024] USD 5.35 billion
Forecast Year [2030] USD 7.83 billion
CAGR (%) 6.54%

Regional Insights

The Americas, particularly the United States and Canada, present a mature landscape for anesthetic drugs, driven by the presence of advanced healthcare architecture, robust healthcare expenditure, and ongoing research and development activities. The need for anesthetic drugs in the U.S. is anchored in the increasing number of surgeries, both elective and emergency, and a growing emphasis on pain management. Recent initiatives include investments in anesthesia research to develop safer, more effective drugs with quicker recovery times and fewer side effects. Patent activities in these countries often revolve around improving drug formulations and delivery methods. The EU countries benefit from a harmonized regulatory framework, which aids in the streamlined process of introducing new anesthetic drugs. The presence of a rapidly aging population also creates a need for effective pain management solutions. Recent research within the EU has focused on minimizing the environmental impact of anesthetic gases alongside enhancing patient outcomes. Asia Pacific region is witnessing rapid growth in the anesthetic drugs market. This growth is spurred by expanding healthcare infrastructure and rising healthcare expenditure. Government initiatives to expand access to healthcare solutions have further propelled the adoption of anesthetic drugs. Morever, the region is also characterized by the expansion of clinics, surgical centers, and private and public hospitals.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Anesthetic Drugs Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing number of surgeries being performed worldwide
      • Significant growth in demand for post-operative pain relief options
      • Rise in aging population and prevalence of cardiovascular and respiratory system-related diseases
    • Market Restraints
      • Side effects associated with drug such as ketamine
    • Market Opportunities
      • Advancements in drug delivery technologies
      • Increasing healthcare expenditure and development of new drugs
    • Market Challenges
      • Dearth of skilled-anesthetics
  • Market Segmentation Analysis
    • Drug Type: Crucial need for general anesthesia drugs for extensive and invasive surgeries
    • Application: Utilization of anesthetic drugs for general surgeries to facilitate effective pain management
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Anesthetic Drugs Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Anesthetic Drugs Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Baxter International Inc. Expands U.S. Portfolio with Innovative Injectable Products

Baxter International Inc. introduced five new injectable products in the U.S. market, addressing critical needs in anti-infective and anti-hypotensive treatments. These products demonstrate Baxter's commitment to innovation and patient care by offering ready-to-use options that potentially enhance operational efficiencies and patient safety in healthcare settings. The launches include a pioneering ready-to-use Norepinephrine Bitartrate in Dextrose Injection available in multiple strengths for treating severe acute hypotension, the first FDA-approved Vasopressin in Sodium Chloride Injection. [Published On: 2024-04-11]

Hikma Pharmaceuticals Broadens US Market Offering with Launch of Fentanyl Citrate Injection

Hikma Pharmaceuticals PLC has expanded its US product range by launching Fentanyl Citrate Injection in doses of 25mcg/0.5mL and 50mcg/mL. This introduction marks the availability of the first FDA-approved 25mcg/0.5mL Fentanyl formulation in the United States, addressing a crucial need in the medical community. The injection is designed for various applications, including short-term analgesia during and after surgery, as a supplemental narcotic analgesic in anesthesia, and for specific high-risk procedures. [Published On: 2024-02-20]

Advancing Postoperative Pain Management: FDA's New Guidance on Developing Long-Lasting Local Anesthetics

The US Food and Drug Administration (FDA) announced a draft guidance aimed at fostering the creation of local anesthetic products with extended effectiveness, potentially lasting several days. This initiative underscores a growing imperative to find alternatives to opioid analgesics by encouraging the development of local anesthetics that offer prolonged pain relief. Recognizing the varying pharmacokinetic profiles among existing local anesthetics, which typically offer a few hours of pain relief, the FDA's guidance is a pivotal step in addressing the pressing need for long-duration analgesic options. [Published On: 2023-03-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Anesthetic Drugs Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Anesthetic Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca PLC, B. Braun Melsungen AG by B. Braun SE, Baxter International Inc., Boehringer Ingelheim International GmbH, Claris Lifesciences Limited, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals PLC, Mylan N.V., Novartis AG, Pacira Pharmaceuticals, Inc., Pfizer Inc., Piramal Enterprises LTD, Septodont Healthcare India Pvt. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Anesthetic Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Type
    • General Anesthesia Drugs
    • Local Anesthesia Drugs
    • Regional Anesthesia
  • Route of Administration
    • Inhalation
    • Injection
  • Application
    • Cosmetic Surgery
    • Dental Surgery
    • General Surgery
    • Plastic Surgery
  • Mode of Administration
    • Inhalational
    • Intravenous
    • Topical:
  • End User
    • Ambulatory Surgical Centers
    • Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of surgeries being performed worldwide
      • 5.1.1.2. Significant growth in demand for post-operative pain relief options
      • 5.1.1.3. Rise in aging population and prevalence of cardiovascular and respiratory system-related diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with drug such as ketamine
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in drug delivery technologies
      • 5.1.3.2. Increasing healthcare expenditure and development of new drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled-anesthetics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Type: Crucial need for general anesthesia drugs for extensive and invasive surgeries
    • 5.2.2. Application: Utilization of anesthetic drugs for general surgeries to facilitate effective pain management
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Anesthetic Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. General Anesthesia Drugs
  • 6.3. Local Anesthesia Drugs
  • 6.4. Regional Anesthesia

7. Anesthetic Drugs Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Inhalation
  • 7.3. Injection

8. Anesthetic Drugs Market, by Application

  • 8.1. Introduction
  • 8.2. Cosmetic Surgery
  • 8.3. Dental Surgery
  • 8.4. General Surgery
  • 8.5. Plastic Surgery

9. Anesthetic Drugs Market, by Mode of Administration

  • 9.1. Introduction
  • 9.2. Inhalational
  • 9.3. Intravenous

9.4. Topical:

10. Anesthetic Drugs Market, by End User

  • 10.1. Introduction
  • 10.2. Ambulatory Surgical Centers
  • 10.3. Clinics
  • 10.4. Hospitals

11. Americas Anesthetic Drugs Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Anesthetic Drugs Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Anesthetic Drugs Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Baxter International Inc. Expands U.S. Portfolio with Innovative Injectable Products
    • 14.3.2. Hikma Pharmaceuticals Broadens US Market Offering with Launch of Fentanyl Citrate Injection
    • 14.3.3. Advancing Postoperative Pain Management: FDA's New Guidance on Developing Long-Lasting Local Anesthetics
  • 14.4. Strategy Analysis & Recommendation

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ANESTHETIC DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANESTHETIC DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ANESTHETIC DRUGS MARKET DYNAMICS
  • FIGURE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. ANESTHETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. ANESTHETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANESTHETIC DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ANESTHETIC DRUGS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHESIA DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL ANESTHESIA DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHESIA DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY LOCAL ANESTHESIA DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY PLASTIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATIONAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INHALATIONAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY TOPICAL:, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY TOPICAL:, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ANESTHETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES ANESTHETIC DRUGS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA ANESTHETIC DRUGS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA ANESTHETIC DRUGS MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY ANESTHETIC DRUGS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)

TABLE 350